Real Options Pricing Model in Biotech Valuation

REAL OPTIONS IN BIOTECHNOLOGICAL FIRMS VALUATION. AN EMPIRICAL ANALYSIS OF EUROPEAN FIRMS.

Attachments

Ziopharm Oncology Thesis.pdf